- Survey respondents use CBD to treat anxiety, depression, insomnia and joint pain
- ADYNF is researching impact of cannabidiol products in treatment of mental health issues and cancers
- 61% of consumers surveyed said they are spending greater than $50 monthly on CBD products
Algae Dynamics Corp. (OTCQB: ADYNF) could be among the chief beneficiaries of a recent survey that found that 42% of respondents chose cannabidiol (CBD), derived from hemp or marijuana, and dropped traditional medicines (http://nnw.fm/6Qu2c). In addition, an “Understanding Cannabidiol” survey of some 2,400 members of HelloMD, an online CBD community, and market research firm Brightfield Group jointly found that, by an overwhelming majority, respondents favored CBD made from cannabis rather than industrial hemp (http://nnw.fm/s2m3Q).
CBD is being used instead of traditional medicines to treat anxiety (67%), insomnia (60%), joint pain and inflammation (52%) and depression (43%). A total of 61% of survey-takers said that they spend more than $50 monthly on CBD products, while more than half of respondents said they use…
More from CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.CannabisNewsWire.com